Industry’s ‘Regulatory Commitments’ Concept Draws FDA’s Interest
This article was originally published in The Gold Sheet
Executive Summary
An industry team is talking up the potential role of what it’s calling ‘regulatory commitments’ to prospectively manage post-approval changes in a way that’s more consistent worldwide. FDA has responded with interest and is engaged in discussions on the idea.